This page shows the latest Prescription Digital Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Pear Therapeutics is a pioneer of so-called digital therapeutics, having gained the first ever such approval from the FDA in 2017, for its treatment for patients with Substance Use Disorder ... Its Prescription Digital Therapeutics (PDTs) are app-based
validated software-based therapeutics, known as Prescription Digital Therapeutics (PDT). ... Richard Francis, CEO, Sandoz. "New digital therapeutics such as reSET-O also have the potential to fundamentally change how patients interact with their
Novartis shares our vision for prescription digital therapeutics that work alongside drugs to deliver superior patient outcomes. ... We believe this collaboration further supports the clinical viability of prescription digital therapeutics as an emerging
Corey McCann, Pear’s president and CEO, said: “This is a defining moment for digital therapeutics and for patients with substance use disorder. ... We believe that prescription digital therapeutics hold promise in improving patient outcomes across a
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Limbix Spark is the first prescription digital therapeutic designed to support adolescents with depression. ... See how Limbix is paving the way for prescription digital therapeutics and learn from their trials, tribulations, successes, and vision for
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...